Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.

<h4>Background</h4>Chronic lymphocytic leukaemia (CLL) is the most common leukaemia among adults in western countries. Considering the increasing incidence and prevalence of this condition, it is highly relevant to better characterise these patients in Portugal, where data is still scarc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fábio Cardoso Borges, Adriana Ramos, António Lourenço, Maria Gomes da Silva, Ana Miranda, ROR-Sul network
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/90ccec87b892444188c33bea6890ebfd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:90ccec87b892444188c33bea6890ebfd
record_format dspace
spelling oai:doaj.org-article:90ccec87b892444188c33bea6890ebfd2021-12-02T20:17:08ZDetailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.1932-620310.1371/journal.pone.0258423https://doaj.org/article/90ccec87b892444188c33bea6890ebfd2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0258423https://doaj.org/toc/1932-6203<h4>Background</h4>Chronic lymphocytic leukaemia (CLL) is the most common leukaemia among adults in western countries. Considering the increasing incidence and prevalence of this condition, it is highly relevant to better characterise these patients in Portugal, where data is still scarce.<h4>Methods</h4>To determine incidence, clinical presentation, survival and second malignancies, a population-based historical cohort study was conducted. Cases of interest were identified through the South Region Cancer Registry database and additional data sources. Patients aged ≥18 years, with a confirmed diagnosis of CLL or small lymphocytic lymphoma between January 1st, 2013 and December 31st, 2014 were included. Patients were followed-up until death or cut-off date (December 31st, 2019).<h4>Results</h4>A total of 496 patients were included and median follow-up time was 5.46 years. Crude incidence rates were 5.03 and 5.22 per 100,000 inhabitants for 2013 and 2014, respectively, and age-adjusted incidence rates were 3.18:100,000 European population for 2013 and 3.35:100,000 European population for 2014. Median age at diagnosis was 71 years and the male/female ratio was 1.40. The majority of patients had leukemic presentation of the disease (86.09%), was diagnosed in Binet stage A (75.58%) and did not present B symptoms (84.01%), anaemia (haemoglobin ≤10g/dL; 90.63%) nor thrombocytopenia (platelet count ≤100 000/μL; 91.73%). Five-year overall survival (OS) rate was 70.53% (95%CI 66.31-74.34) and age, lactate dehydrogenase, Binet stage and a ≥5 Charlson comorbidity index score were independently associated with OS. Standardised-incidence ratios for any second malignancy and cutaneous squamous cell carcinoma were 1.59 (95%CI 1.19-2.08) and 10.15 (95%CI 6.28-15.51), respectively.<h4>Conclusion</h4>Incidence, clinical presentation and survival of CLL Portuguese patients are similar to those reported for other western countries. The increased risk of second malignancies raises concerns and needs adequate clinical watchfulness.Fábio Cardoso BorgesAdriana RamosAntónio LourençoMaria Gomes da SilvaAna MirandaROR-Sul networkPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 10, p e0258423 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Fábio Cardoso Borges
Adriana Ramos
António Lourenço
Maria Gomes da Silva
Ana Miranda
ROR-Sul network
Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.
description <h4>Background</h4>Chronic lymphocytic leukaemia (CLL) is the most common leukaemia among adults in western countries. Considering the increasing incidence and prevalence of this condition, it is highly relevant to better characterise these patients in Portugal, where data is still scarce.<h4>Methods</h4>To determine incidence, clinical presentation, survival and second malignancies, a population-based historical cohort study was conducted. Cases of interest were identified through the South Region Cancer Registry database and additional data sources. Patients aged ≥18 years, with a confirmed diagnosis of CLL or small lymphocytic lymphoma between January 1st, 2013 and December 31st, 2014 were included. Patients were followed-up until death or cut-off date (December 31st, 2019).<h4>Results</h4>A total of 496 patients were included and median follow-up time was 5.46 years. Crude incidence rates were 5.03 and 5.22 per 100,000 inhabitants for 2013 and 2014, respectively, and age-adjusted incidence rates were 3.18:100,000 European population for 2013 and 3.35:100,000 European population for 2014. Median age at diagnosis was 71 years and the male/female ratio was 1.40. The majority of patients had leukemic presentation of the disease (86.09%), was diagnosed in Binet stage A (75.58%) and did not present B symptoms (84.01%), anaemia (haemoglobin ≤10g/dL; 90.63%) nor thrombocytopenia (platelet count ≤100 000/μL; 91.73%). Five-year overall survival (OS) rate was 70.53% (95%CI 66.31-74.34) and age, lactate dehydrogenase, Binet stage and a ≥5 Charlson comorbidity index score were independently associated with OS. Standardised-incidence ratios for any second malignancy and cutaneous squamous cell carcinoma were 1.59 (95%CI 1.19-2.08) and 10.15 (95%CI 6.28-15.51), respectively.<h4>Conclusion</h4>Incidence, clinical presentation and survival of CLL Portuguese patients are similar to those reported for other western countries. The increased risk of second malignancies raises concerns and needs adequate clinical watchfulness.
format article
author Fábio Cardoso Borges
Adriana Ramos
António Lourenço
Maria Gomes da Silva
Ana Miranda
ROR-Sul network
author_facet Fábio Cardoso Borges
Adriana Ramos
António Lourenço
Maria Gomes da Silva
Ana Miranda
ROR-Sul network
author_sort Fábio Cardoso Borges
title Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.
title_short Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.
title_full Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.
title_fullStr Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.
title_full_unstemmed Detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in Portugal-Results from a population-based cancer registry cohort study.
title_sort detailing the epidemiological and clinical characteristics of chronic lymphocytic leukaemia in portugal-results from a population-based cancer registry cohort study.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/90ccec87b892444188c33bea6890ebfd
work_keys_str_mv AT fabiocardosoborges detailingtheepidemiologicalandclinicalcharacteristicsofchroniclymphocyticleukaemiainportugalresultsfromapopulationbasedcancerregistrycohortstudy
AT adrianaramos detailingtheepidemiologicalandclinicalcharacteristicsofchroniclymphocyticleukaemiainportugalresultsfromapopulationbasedcancerregistrycohortstudy
AT antoniolourenco detailingtheepidemiologicalandclinicalcharacteristicsofchroniclymphocyticleukaemiainportugalresultsfromapopulationbasedcancerregistrycohortstudy
AT mariagomesdasilva detailingtheepidemiologicalandclinicalcharacteristicsofchroniclymphocyticleukaemiainportugalresultsfromapopulationbasedcancerregistrycohortstudy
AT anamiranda detailingtheepidemiologicalandclinicalcharacteristicsofchroniclymphocyticleukaemiainportugalresultsfromapopulationbasedcancerregistrycohortstudy
AT rorsulnetwork detailingtheepidemiologicalandclinicalcharacteristicsofchroniclymphocyticleukaemiainportugalresultsfromapopulationbasedcancerregistrycohortstudy
_version_ 1718374418752733184